• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

同时组装非诺贝特和酮洛芬肽用于非酒精性脂肪性肝病（NAFLD）的双重靶向治疗。

Simultaneous co-assembly of fenofibrate and ketoprofen peptide for the dual-targeted treatment of nonalcoholic fatty liver disease (NAFLD).

机构信息

Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, P. R. China.

出版信息

Chem Commun (Camb). 2020 May 4;56(36):4922-4925. doi: 10.1039/d0cc00513d. Epub 2020 Apr 2.

DOI:10.1039/d0cc00513d
PMID:32239031
Abstract

We have developed a co-assembled nanosystem based on fenofibrate and ketoprofen by tactfully utilizing their simultaneous benzophenone interaction, which greatly enhances the bioavailability of fenofibrate and plays a role in the dual-targeted treatment of NAFLD by reducing hepatic lipid accumulation and inflammatory responses.

摘要

我们开发了一种基于非诺贝特和酮洛芬的共组装纳米系统，巧妙地利用了它们的同时苯甲酮相互作用，极大地提高了非诺贝特的生物利用度，并通过减少肝脂质积累和炎症反应发挥双重靶向治疗非酒精性脂肪性肝病（NAFLD）的作用。

相似文献

1
Simultaneous co-assembly of fenofibrate and ketoprofen peptide for the dual-targeted treatment of nonalcoholic fatty liver disease (NAFLD).同时组装非诺贝特和酮洛芬肽用于非酒精性脂肪性肝病（NAFLD）的双重靶向治疗。
Chem Commun (Camb). 2020 May 4;56(36):4922-4925. doi: 10.1039/d0cc00513d. Epub 2020 Apr 2.
2
Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats.油酰乙醇胺对大鼠饮食诱导的非酒精性脂肪肝的影响。
J Pharmacol Sci. 2015 Mar;127(3):244-50. doi: 10.1016/j.jphs.2014.12.001. Epub 2014 Dec 9.
3
Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice.非诺贝特治疗减轻了非酒精性脂肪性肝病小鼠肝脏中的慢性内质网应激。
Pharmacology. 2015;95(3-4):173-80. doi: 10.1159/000380952. Epub 2015 Apr 16.
4
Omega-3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non-alcoholic fatty liver disease.ω-3 羧酸和非诺贝特对非酒精性脂肪性肝病患者血浆脂质介质的影响不同。
FASEB J. 2021 Nov;35(11):e21976. doi: 10.1096/fj.202100380RRR.
5
Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia.长期 PM2.5 暴露通过引发血脂异常增加，增加了由氧化应激驱动的非酒精性脂肪性肝病的风险。
Free Radic Biol Med. 2019 Jan;130:542-556. doi: 10.1016/j.freeradbiomed.2018.11.016. Epub 2018 Nov 19.
6
Impact of fenofibrate on NAFLD/NASH: A genetic perspective.非诺贝特对非酒精性脂肪性肝病/非酒精性脂肪性肝炎的影响：遗传视角。
Drug Discov Today. 2022 Aug;27(8):2363-2372. doi: 10.1016/j.drudis.2022.05.007. Epub 2022 May 17.
7
Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice.壳寡糖通过减少 C57BL/6 小鼠的脂肪积累、炎症和氧化应激来减轻高脂饮食诱导的非酒精性脂肪肝病。
Mar Drugs. 2019 Nov 16;17(11):645. doi: 10.3390/md17110645.
8
Photodermatitis from ketoprofen with cross-reactivity to fenofibrate and benzophenones.酮洛芬引起的光性皮炎，与非诺贝特和二苯甲酮存在交叉反应。
Photodermatol Photoimmunol Photomed. 1997 Jun;13(3):93-7. doi: 10.1111/j.1600-0781.1997.tb00123.x.
9
PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.过氧化物酶体增殖物激活受体α/γ激动剂和拮抗剂对脂肪性肝炎大鼠的肝脏脂质代谢、氧化应激及炎性细胞因子产生有不同影响。
Cytokine. 2015 Sep;75(1):127-35. doi: 10.1016/j.cyto.2015.05.031. Epub 2015 Jul 17.
10
Fenofibrate nanoliposome: Preparation and its inhibitory effects on nonalcoholic fatty liver disease in mice.非诺贝特纳米脂质体：制备及其对小鼠非酒精性脂肪性肝病的抑制作用
Nanomedicine. 2016 Nov;12(8):2449-2458. doi: 10.1016/j.nano.2016.07.002. Epub 2016 Jul 18.

引用本文的文献

1
Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection.非酒精性脂肪性肝病中的治疗性纳米材料：在合并乙型肝炎病毒感染患者中的当前进展及潜在应用
Int J Nanomedicine. 2025 Mar 25;20:3803-3823. doi: 10.2147/IJN.S510271. eCollection 2025.
2
An Exploration of Multiple Component Peptide Assemblies by Enzyme-Instructed Self-Assembly.通过酶促自组装对多组分肽组装体的探索
ChemSystemsChem. 2023 May;5(3). doi: 10.1002/syst.202200041. Epub 2023 Jan 18.
3
Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models.
非诺贝特在非酒精性脂肪性肝炎/非酒精性脂肪性肝病动物模型中的肝脏保护作用。
PPAR Res. 2022 Jun 17;2022:5805398. doi: 10.1155/2022/5805398. eCollection 2022.
4
Paclitaxel-based supramolecular hydrogel loaded with mifepristone for the inhibition of breast cancer metastasis.载米非司酮的紫杉醇基超分子水凝胶抑制乳腺癌转移。
Cancer Sci. 2022 Feb;113(2):733-743. doi: 10.1111/cas.15230. Epub 2021 Dec 18.
5
Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE Mice.黄芪黄酮通过抑制载脂蛋白E基因敲除小鼠的脂质紊乱和炎症来改善动脉粥样硬化和肝脂肪变性。
Front Pharmacol. 2020 Dec 14;11:610550. doi: 10.3389/fphar.2020.610550. eCollection 2020.
6
Co-assembled Supramolecular Nanofibers With Tunable Surface Properties for Efficient Vaccine Delivery.具有可调节表面性质的共组装超分子纳米纤维用于高效疫苗递送
Front Chem. 2020 Jul 21;8:500. doi: 10.3389/fchem.2020.00500. eCollection 2020.
7
Enzymatic Noncovalent Synthesis.酶非共价合成。
Chem Rev. 2020 Sep 23;120(18):9994-10078. doi: 10.1021/acs.chemrev.0c00306. Epub 2020 Aug 19.
8
The ratio of hydrogelator to precursor controls the enzymatic hydrogelation of a branched peptide.水凝胶剂与前体的比例控制着一种支链肽的酶促水凝胶化过程。
Soft Matter. 2020 Nov 18;16(44):10101-10105. doi: 10.1039/d0sm00867b.